EUVIMEDEUVIMED entdecken
Open Access

Altered microRNA expression in patients with sarcoidosis.

Rajen Morar, Caroline Dickens, Therese Dix-Peek, Raquel Duarte, Charles Feldman

Sarcoidosis vasculitis and diffuse lung diseases · 13.09.2023 · 40 (3) · e2023037-e2023037

DOI: 10.36141/svdld.v40i3.13399 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sarcoidosis vasculitis and diffuse lung diseases, erschienen am 13.09.2023. Verfasst von Rajen Morar und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of the Witwatersrand. rajenmorar@webmail.co.za. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sarcoidosis is a granulomatous multisystem disease of uncertain aetiology. The disease has major inflammatory and immune components; however, the immunopathogenesis is not well understood. Micro ribonucleic acids (microRNAs) are classes of miniature, single-stranded, non-coding RNAs. Their key recognised role includes mediating the silencing of target genes post-transcriptionally. Recently, the role of miRNAs has gained interest in numerous disorders, suggested as being involved in pathogenesis of those diseases and acting as disease markers. Very little is known about the role of miRNAs in sarcoidosis, with nothing known regarding miRNAs in South African patients. The main objective, therefore, was to investigate the serum expression of approximately 800 miRNAs in patients with sarcoidosis compared with race-, age- and gender-matched healthy controls.

Methods

A total of six patients and six matched controls participated in this study. Whole blood samples were collected in EDTA tubes, processed and the plasma retained. RNA was extracted from the stored plasma samples using the QIAGEN miRNeasy Mini Kit® and concentrated using a salt-ethanol precipitation. The extracted miRNA was profiled using an nCounter® miRNA human v3 expression assay and data analysed using the nSolver™ Analysis Software.

Results

After excluding one sample/control pair because of cellular RNA contamination, the remaining five patient and five matched control samples were analysed, and 145 miRNAs were found to be potentially differentially expressed. On applying a Bonferroni correction, the only miRNA that was significantly different was miRNA let-7a-5p, which was significantly overexpressed (141-fold change; p

Schlagwörter

sarcoidosismicroRNA expressionserum microRNAlet-7a-5pmiRNA expression profilinggranulomatous diseasepathogenesisbiomarkersSouth African patients

Autor:innen und Institutionen

  • University of the Witwatersrand. rajenmorar@webmail.co.za.
  • . caroline.dickens@wits.ac.za.
  • . Terese.dix-peek@wits.ac.za.
  • . raquel.duarte@wits.ac.za.
  • . charles.feldman@wits.ac.za.

Zitieren

APA

Morar, R., Dickens, C., Dix-Peek, T., Duarte, R., & Feldman, C. (2023). Altered microRNA expression in patients with sarcoidosis. Sarcoidosis vasculitis and diffuse lung diseases, 40(3), e2023037-e2023037. https://doi.org/10.36141/svdld.v40i3.13399

Vancouver

Morar R, Dickens C, Dix-Peek T, Duarte R, Feldman C. Altered microRNA expression in patients with sarcoidosis. Sarcoidosis vasculitis and diffuse lung diseases. 2023;40(3):e2023037-e2023037. doi:10.36141/svdld.v40i3.13399

BibTeX
@article{Morar2023,
  author = {Morar, Rajen and Dickens, Caroline and Dix-Peek, Therese and Duarte, Raquel and Feldman, Charles},
  title = {Altered microRNA expression in patients with sarcoidosis},
  journal = {Sarcoidosis vasculitis and diffuse lung diseases},
  year = {2023},
  volume = {40},
  number = {3},
  pages = {e2023037--e2023037},
  doi = {10.36141/svdld.v40i3.13399}
}
Kostenlos starten →